Norris Medicines Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 24	Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21

Sales

1.99

3.50

3.98

2.35

7.09

Operating profit

-0.31

-0.63

0.04

-0.46

0.39

Interest

0.17

0.17

0.74

0.56

0.92

Gross profit

-0.46

-0.80

-0.70

-1.01

-0.52

EPS (Rs)

-0.73

-1.10

-1.01

-2.44

-0.85

Other income

0.01

-

-

0.01

0.02

Stock adjustment

0.38

-0.03

-0.58

0.01

2.03

Raw material

0.73

2.41

2.53

1.17

2.40

Power and fuel

-

-

-

-

-

Employee expenses

0.63

1.07

1.05

1.03

1.30

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

0.57

0.67

0.95

0.60

0.98

Provisions made

-

-

-

-

-

Depreciation

0.26

0.29

0.30

0.33

0.32

Taxation

-

-

-

1.08

-

Net profit / loss

-0.73

-1.09

-1.00

-2.42

-0.84

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

9.93

9.93

9.93

9.93

9.93

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-15.36

-18.01

1.04

-19.54

5.45

GPM (%)

-23.06

-

-

-42.77

-7.32

NPM (%)

-36.25

-

-

-102.75

-11.86